Genomenon, Inc., a pioneering force in genomic data analysis, is headquartered in the United States. Founded in 2013, the company has rapidly established itself within the biotechnology industry, focusing on innovative solutions for genomic research and clinical applications. Genomenon’s flagship product, the Mastermind Genomic Search Engine, uniquely integrates genomic data with clinical insights, enabling researchers and healthcare professionals to make informed decisions. This powerful tool streamlines the process of variant interpretation, significantly enhancing the efficiency of genomic studies. With a strong market position, Genomenon has garnered recognition for its contributions to precision medicine, helping to bridge the gap between genomic information and actionable insights. The company continues to expand its operational reach, supporting advancements in personalised healthcare across various regions.
How does Genomenon, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genomenon, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genomenon, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Genomenon may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is challenging to assess Genomenon's position relative to its peers in the biotechnology sector.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomenon, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.